SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001140361-23-025742
Filing Date
2023-05-19
Accepted
2023-05-19 16:05:38
Documents
1
Period of Report
2023-05-17

Document Format Files

Seq Description Document Type Size
1 form4.html 4  
1 form4.xml 4 4611
  Complete submission text file 0001140361-23-025742.txt   6053
Mailing Address 350 FIFTH AVENUE SUITE 7530 NEW YORK NY 10118
Business Address 350 FIFTH AVENUE SUITE 7530 NEW YORK NY 10118 646-440-9100
ROCKET PHARMACEUTICALS, INC. (Issuer) CIK: 0001281895 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 430 EAST 29TH STREET SUITE 1040 NEW YORK NY 10016
Business Address
Shah Gaurav (Reporting) CIK: 0001725922 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-36829 | Film No.: 23940013